Somatostatin, tyr(11)- is a synthetic peptide compound used as an active pharmaceutical ingredient. It is a modified analog of the natural hormone somatostatin, characterized by a tyrosine residue at position 11 and a disulfide bridge, functioning as a research compound in endocrinology.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing Somatostatin, tyr(11)-?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
Somatostatin
pharmaceutical raw material
Somatostatin
pharmaceutical raw material
Tafamidis
pharmaceutical raw material
Megestrol acetate
pharmaceutical raw material
Algestone
pharmaceutical raw material
Berberine chloride dihydrate
pharmaceutical raw material
(4R,7S,13R,19R,22S,25S,34S,37S)-19,34-bis(4-aminobutyl)-31-(2-amino-2-oxoethyl)-37-[[2-[[(2S)-2-aminopropanoyl]amino]acetyl]amino]-25,28-dibenzyl-10,16-bis[(1R)-1-hydroxyethyl]-7-(hydroxymethyl)-13-[(4-hydroxyphenyl)methyl]-22-(1H-indol-2-ylmethyl)-6,9,12,15,18,21,24,27,30,33,36-undecaoxo-1,2-dithia-5,8,11,14,17,20,23,26,29,32,35-undecazacyclooctatriacontane-4-carboxylic acid
BANSKZGUYZBDPC-GWVZWCPESA-N
C[C@H](C1C(=O)N[C@@H](C(=O)NC(C(=O)N[C@H](C(=O)N[C@@H](CSSC[C@H](C(=O)N[C@H](C(=O)NC(C(=O)NC(C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N1)CCCCN)CC2=CC3=CC=CC=C3N2)CC4=CC=CC=C4)CC5=CC=CC=C5)CC(=O)N)CCCCN)NC(=O)CNC(=O)[C@H](C)N)C(=O)O)CO)[C@@H](C)O)CC6=CC=C(C=C6)O)O
Sourcing Somatostatin, tyr(11)-?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.